Unilife Corporation

Amgen has invested £53.8m ($75m) in Unilife Corperation as part of a joint agreement to produce wearable injectors Read more


Unilife’s agreement with Sanofi to be the sole provider of cartridge based wearable injectors is ‘unprecedented’, according to Alan Shortall, Chairman and Chief Executive Officer at the firm. Read more


Unilife Corporation has been chosen to act as the sole supplier of cartridge-based wearable injectors for all of Sanofi's applicable large dose volume drugs (excluding insulins). Read more